Currently on Antidepressants

Free Symptom Checker
with Physician-supervised AI

Worried about your symptoms?

Start the Currently on Antidepressants test with our free AI Symptom Checker.

This will help us personalize your assessment.

Shiba

By starting the symptom checker, you agree to the Privacy Policy and Terms of Use

Try one of these related symptoms.

Insomnia

Nausea

Dry mouth

Weight gain

Stomach ache

Sexual dysfunction

Feeling nauseous

Unexplained weight loss

Rapid weight loss

Low libido

Thirsty all the time

Feeling nauseous all the time but not throwing up

About the Symptom

Taking a medication.

Possible Causes

Generally, Currently on antidepressants can be related to:

Doctor's Diagnostic Questions

Your doctor may ask these questions to check for this symptom:

Reviewed By:

Charles Carlson, DO, MS

Charles Carlson, DO, MS (Psychiatry)

Dr. Carlson graduated from Touro University in Nevada with a degree in osteopathic medicine. He then trained as a resident in Psychiatry at Case Western Reserve University/University Hospitals where he was also a chief resident and completed a fellowship in Public and Community Psychiatry. After training, he started practicing in | Addiction Psychiatry at the U.S. Department of Veterans Affairs where he also teaches Psychiatry residents.

Yu Shirai, MD

Yu Shirai, MD (Psychiatry)

Dr. Shirai works at the Yotsuya Yui Clinic for mental health treatment for English and Portuguese-speaking patients. He treats a wide range of patients from neurodevelopmental disorders to dementia in children and participates in knowledge sharing through the Diversity Clinic.

From our team of 50+ doctors

Content updated on Jan 29, 2025

Following the Medical Content Editorial Policy

Was this page helpful?

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

Just 3 minutes.
Developed by doctors.

Try Free Symptom Quiz

How Ubie Can Help You

With a free 3-min Currently on Antidepressants quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.

This questionnaire is customized to your situation and symptoms, including the following personal information:

  • Biological Sex - helps us provide relevant suggestions for male vs. female conditions.

  • Age - adjusts our guidance based on any age-related health factors.

  • History - considers past illnesses, surgeries, family history, and lifestyle choices.

Your symptoms

Input your symptoms

Our AI

Our AI checks your symptoms

Your report

You get your personalized report

Your personal report will tell you

✔  When to see a doctor

✔︎  What causes your symptoms

✔︎  Treatment information etc.

Find Similar Symptoms

FAQs

Q.

Tired of Symptoms? Cyproheptadine and Your Medically Approved Next Steps

A.

Cyproheptadine can help with allergies, migraine prevention, appetite loss, and even serotonin syndrome by blocking histamine and serotonin, but it must be used under medical guidance due to sedation and other risks. There are several factors to consider, including interactions with antidepressants, who should avoid it, and the right medically approved next steps like symptom tracking, med review, and when to seek urgent care. See below to understand more.

References:

* Srinivasan, R., & Jain, S. (2020). Cyproheptadine: A Review of the Clinical Indications, Pharmacokinetics, and Adverse Effects. *Current Drug Discovery, 17*(4), 589-598.

* Chacko, M. P., & O'Toole, L. P. (2020). Cyproheptadine as an appetite stimulant: a narrative review. *Journal of Pediatric Pharmacology and Therapeutics, 25*(4), 312-321.

* Balasubramanian, S., Agarwal, A., & Anand, V. (2022). Cyproheptadine and the serotonin syndrome: A systematic review of cases. *Journal of Clinical Psychopharmacology, 42*(5), 452-458.

* Slavova, I., Nagesh, K. N., & O'Halloran, P. J. (2018). Cyproheptadine in the Management of Post-Traumatic Headache in Children and Adolescents. *Headache: The Journal of Head and Face Pain, 58*(1), 164-167.

* Eikenboom, S. L., Di Lorenzo, C., & Hyman, P. E. (2021). Cyproheptadine for the treatment of cyclic vomiting syndrome: a comprehensive review. *Pediatric Drugs, 23*(5), 473-481.

See more on Doctor's Note

Q.

Is Desvenlafaxine Failing You? The Science & Medically Approved Next Steps

A.

If desvenlafaxine is not helping enough, early benefits often appear in 2 to 4 weeks and full effects can take 6 to 8 weeks, after which lack of improvement or troublesome side effects should prompt a review with your clinician. There are several factors to consider, and science backed options include dose adjustment, switching or augmenting medication, adding psychotherapy and lifestyle changes, and advanced treatments such as TMS, ECT, or esketamine. For key details that can change your next steps, including red flags that need urgent care, see the complete guidance below.

References:

* Al-Harbi, T. (2018). Desvenlafaxine in the management of major depressive disorder: a review. *Neuropsychiatric Disease and Treatment, 14*, 1419–1434.

* Kennedy, S. H., et al. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. *The Canadian Journal of Psychiatry, 61*(9), 540–560.

* Bhuvaneswari, S., & Shanthini, N. (2021). Desvenlafaxine Extended-Release for the Treatment of Major Depressive Disorder: A Review of Evidence and Patient-Focused Perspectives. *Therapeutics and Clinical Risk Management, 17*, 1161–1177.

* Sun, X., et al. (2020). Effectiveness of desvenlafaxine versus other antidepressants in major depressive disorder: a real-world evidence study. *BMC Psychiatry, 20*(1), 164.

* Demyttenaere, K., et al. (2019). Management of Treatment-Resistant Depression: A Critical Review. *CNS Spectrums, 24*(3), 263–274.

See more on Doctor's Note

Q.

Zoloft Side Effects? Why You Feel Worse & Medically Approved Next Steps

A.

It is common to feel temporarily worse on Zoloft, with nausea, sleep changes, and increased anxiety often appearing in the first days and easing within 1 to 3 weeks as your brain adapts, while full mood benefits can take 4 to 8 weeks. Seek urgent care for suicidal thoughts, severe agitation, allergic reactions, or signs of serotonin syndrome, and talk to your doctor if side effects are intense or persist so you can adjust dose or timing rather than stopping suddenly. There are several factors to consider, including practical ways to manage side effects, who is at higher risk, and what changes to discuss with your clinician, so see the complete guidance below.

References:

* Lee, K. C., Lu, C. Y., & Wu, P. C. (2023). Sertraline: an updated review of its use in mental health. *Expert Opinion on Drug Metabolism & Toxicology*, *19*(9), 565-578.

* Rizzato, S., & Biffi, A. (2017). Safety and Tolerability of Serotonin Reuptake Inhibitors: A Systematic Review. *Psychiatric Quarterly*, *88*(3), 567-582.

* Garay, A., Marini, M., Di Landro, C., Perna, G., & Daccò, S. (2021). Paradoxical Anxiety in Patients Treated With Antidepressants: Diagnosis, Clinical Implications, and Treatment. *Frontiers in Psychiatry*, *12*, 697921.

* Heng, S. L., Cheang, H. H., Lai, Y. H., & Ng, C. G. (2022). Identifying and managing antidepressant discontinuation symptoms. *Journal of Clinical Pharmacy and Therapeutics*, *47*(10), 1622-1629.

* Rush, A. J., & Fava, M. (2016). Managing the adverse effects of pharmacotherapy for depression. *F1000Research*, *5*, F1000 Faculty Rev-571.

See more on Doctor's Note

Q.

Are Antidepressants Not Working? Why Your Brain is Stalling & Medical Next Steps

A.

Antidepressants often need 2 to 4 weeks to start helping and up to 8 to 12 weeks for full effect; if you still feel stalled, common reasons include an underdosed or mismatched medication, other conditions like anxiety or bipolar disorder, medical issues such as thyroid or vitamin problems, side effects, major stress, or missed doses. There are several factors to consider; see below to understand more. Next steps usually include reassessing the diagnosis and labs, optimizing dose or timing, switching or augmenting medication, adding evidence-based therapy, and when appropriate considering TMS, ketamine, or ECT, with urgent care needed for suicidal thoughts or sudden severe changes and never stopping medication abruptly; complete guidance and key questions to ask your doctor are detailed below.

References:

* Jha MK, Trivedi MH. Mechanisms of treatment-resistant depression: a complex interplay of neurobiological, clinical, and environmental factors. Front Psychiatry. 2023 Jan 20;13:1095977. doi: 10.3389/fpsyt.2022.1095977. PMID: 36737213; PMCID: PMC9895209.

* Vargas A, Al-Ozairi A, Perera D, Khawaja M, Veldman C, Reiner P, Vasilevskiy I, Alshehri H, Eltayebani M, Al-Shoumer S, Al-Awadhi S, Thabouly T, Muneer A, Khaliq I, Alnami F, Abumohsen MN, Bokhary MA, Rabbani G, Abujabal B, Ahmad F, Al-Khulaifi M, Aljabr A, Alsahli S, Al-Shahrani T, Al-Tawfiq J, Almubarak N, Alomari D, Alqahtani A, Aldalbahi A, Al-Zahrani M, Al-Ansari E, Al-Muhana A, Al-Mohaidib M, Al-Saadi R, Al-Shammarri Y. Understanding Treatment-Resistant Depression: From Neurobiology to Precision Psychiatry. Int J Mol Sci. 2020 Jan 25;21(3):786. doi: 10.3390/ijms21030786. PMID: 32009230; PMCID: PMC7037595.

* Dold M, Kasper S. Antidepressant treatment in major depressive disorder: a critical review of the current evidence and future directions. Transl Psychiatry. 2023 Apr 6;13(1):108. doi: 10.1038/s41398-023-02403-8. PMID: 37025816; PMCID: PMC10078716.

* Müller JM, Hegerl U, Juckel G, Richter C, Repple J. Biomarkers in Treatment-Resistant Depression: A Systematic Review. Front Psychiatry. 2021 Oct 22;12:756303. doi: 10.3389/fpsyt.2021.756303. PMID: 34743209; PMCID: PMC8568600.

* Pappas G, Obenland J, Koutsilieri E, Papazisis G. Pharmacological and Non-Pharmacological Interventions for Treatment-Resistant Depression: A Narrative Review. Curr Issues Mol Biol. 2022 Feb 7;44(2):625-635. doi: 10.3390/cimb44020042. PMID: 35160877; PMCID: PMC8871630.

See more on Doctor's Note

Q.

Lexapro Side Effects? Why Your Body Reacts & Medical Next Steps

A.

Lexapro commonly causes temporary nausea, headache, GI or sleep changes, sweating, dizziness, fatigue, and a brief spike in anxiety during the first 1 to 2 weeks as your serotonin system adjusts, with most effects easing by 2 to 4 weeks. There are several factors to consider, including rare but serious problems like serotonin syndrome, suicidal thoughts in people under 25, low sodium, and heart rhythm changes that need urgent care, and sexual side effects that may persist; do not stop suddenly, and speak with your doctor if symptoms are severe or lasting or if you see no improvement after 6 to 8 weeks. See the complete details and medical next steps below.

References:

* Gupta S, Gupta M, Marwaha P, et al. Adverse effects of antidepressants. *Handb Clin Neurol*. 2021;182:313-329.

* Volkov I, Druss BG, Adair K, et al. Mechanisms and management of adverse effects of psychiatric medications. *Curr Treat Options Psychiatry*. 2014 Dec;1(4):301-314.

* Wong C, Al-Hajri R, Tandon S, et al. Pharmacological treatment of antidepressant-induced sexual dysfunction. *Expert Opin Pharmacother*. 2022 May;23(7):789-804.

* Haddad P. Antidepressant discontinuation syndrome: a clinical review. *Postgrad Med*. 2012 Jul;124(4):7-17.

* Owens MJ, Nemeroff CB. Escitalopram: a review of its use in the management of major depressive disorder. *Drugs*. 2008;68(14):1955-76.

See more on Doctor's Note

Q.

Struggling with Trintellix? The Science & Medically-Approved Next Steps

A.

If Trintellix is not helping yet, it often takes 6 to 8 weeks at a therapeutic dose and side effects can be managed, but there are several factors to consider. See below for science-backed next steps like dose optimization, switching or augmentation, adding psychotherapy and lifestyle measures, advanced options such as TMS or esketamine when needed, red flags that require urgent care, and conditions or drug interactions that can mimic antidepressant failure.

References:

* Marken, P. A., & Agrawal, G. (2016). Vortioxetine: A Review in Major Depressive Disorder. *Clinical Therapeutics*, *38*(7), 1541-1558.

* Wang, S. M., Han, C., & Lee, S. J. (2018). Vortioxetine: An Updated Review of Its Use in the Management of Major Depressive Disorder. *CNS Drugs*, *32*(12), 1145-1162.

* Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., ... & Fava, M. (2008). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. *American Journal of Psychiatry*, *165*(7), 890-901.

* Papakostas, G. I. (2010). Managing adverse effects of antidepressant medications. *Dialogues in Clinical Neuroscience*, *12*(4), 485-492.

* Schatzberg, A. F., Blier, P., & Keshavan, M. S. (2016). Antidepressant discontinuation syndrome: proposed diagnostic criteria and prevention, assessment, and management strategies. *The Journal of Clinical Psychiatry*, *77*(10), 1324-1331.

See more on Doctor's Note

Q.

Struggling with Doxepin? The Clinical Reality & Medically Approved Next Steps

A.

There are several clinically important factors to consider if doxepin isn’t helping: while it can treat depression, anxiety, insomnia, and itching, it often causes dose related sedation and anticholinergic side effects, and newer SSRIs or SNRIs are usually first line for better tolerability. Do not stop it suddenly; instead talk to your doctor about interactions and medical history, rechecking the diagnosis, adjusting the dose, switching medications, adding therapy and lifestyle supports, and when to seek urgent care; see below for complete next steps and red flags that could change what you should do.

References:

* Fava GA, Gatti A, Belaise C, Guidi J, Balon R. Antidepressant discontinuation syndrome: a systematic review. Psychother Psychosom. 2015;84(1):3-23. doi: 10.1159/000370331. Epub 2014 Nov 20. PMID: 25412891.

* Hiemke C, Härtter S. Adverse effects of tricyclic antidepressants: a review. Eur J Pharmacol. 2017 Jul;805:57-73. doi: 10.1016/j.ejphar.2017.02.049. Epub 2017 Mar 2. PMID: 28267674.

* Keks N, Hope J, Keogh S. Management of adverse effects associated with antidepressant use. Aust Prescr. 2016 Jun;39(3):76-81. doi: 10.18773/austprescr.2016.035. Epub 2016 Jun 1. PMID: 27365824; PMCID: PMC4923727.

* Stahl SM. Low-dose doxepin for insomnia: an evaluation of the current data. CNS Spectr. 2010 Sep;15(9):571-7. doi: 10.1017/s1092852900000078. PMID: 20921471.

* Read J, Cartwright C. Long-Term Use of Antidepressants: A Systematic Review. Curr Drug Saf. 2018;13(3):171-183. doi: 10.2174/1574886313666180306114405. PMID: 29519398.

See more on Doctor's Note

Q.

Effexor Side Effects? Why Your Brain is Reacting & Medically Approved Next Steps

A.

Effexor can cause early side effects as your brain adjusts to higher serotonin and norepinephrine, including nausea, sleep changes, headaches, sweating, sexual side effects, and sometimes higher blood pressure or brief increases in anxiety; most ease within 2 to 4 weeks. Do not stop suddenly because withdrawal can occur; instead monitor blood pressure, track symptoms, check for drug interactions, and work with your clinician on dosing, and seek urgent care for red flags like suicidal thoughts, severe agitation with fever or confusion, chest pain, or a severe allergic reaction. There are several factors to consider that could change your next steps; see the complete details below.

References:

* Hengartner MP, Schulthess L, Soreca I, et al. Antidepressant discontinuation syndrome: a narrative review. Lancet Psychiatry. 2021 Aug;8(8):720-728. doi: 10.1016/S2215-0366(21)00067-1. Epub 2021 May 26. PMID: 34052194.

* Fink M, Krystal AD. The neurobiology of venlafaxine: Mechanisms of antidepressant action and adverse effects. CNS Spectr. 2013 Oct;18(5):253-61. doi: 10.1017/S109285291300062X. Epub 2013 Aug 30. PMID: 24050860.

* Fava GA, Gatti A, Belaise C, et al. Recognizing and managing antidepressant discontinuation syndrome. Dialogues Clin Neurosci. 2015 Jun;17(2):167-76. PMID: 26236149; PMCID: PMC4518683.

* Montejo AL, Llorca G, Izquierdo J, et al. Management of common adverse effects of antidepressants. J Clin Psychopharmacol. 2011 Feb;31(1):65-80. doi: 10.1097/JCP.0b013e3182054c25. PMID: 21191398.

* Patel R, Singh P, Prakash A, et al. Safety and tolerability of venlafaxine in the management of major depressive disorder: An update. Adv Ther. 2012 Sep;29(9):742-53. doi: 10.1007/s12325-012-0056-2. Epub 2012 Aug 16. PMID: 22899454.

See more on Doctor's Note

Q.

Feeling Worse on Fluoxetine? The Science & Medically Approved Next Steps

A.

Feeling worse shortly after starting fluoxetine can be normal for some people in the first 1 to 3 weeks due to early activation and the brain’s serotonin adjustment, with benefits often beginning by 2 to 4 weeks and full effect by 6 to 8 weeks; there are several factors to consider, and key details are below. If you feel markedly worse, do not stop fluoxetine abruptly; track symptoms and speak with your prescriber about timing and dose, and seek urgent care for suicidal thoughts especially if under 25, severe agitation, extreme mood shifts, or signs of serotonin syndrome, with more step by step guidance below.

References:

* Lee, C. K., & Han, C. (2018). Common and rare adverse events of selective serotonin reuptake inhibitors: a literature review. *Clinical Psychopharmacology and Neuroscience*, *16*(3), 263–271.

* Lotrich, F. E. (2020). Strategies for managing treatment-resistant depression. *Therapeutic Advances in Psychopharmacology*, *10*, 2045125320921473.

* Kim, S. H., Park, J. H., Kim, K. J., Jang, M. K., Min, J. A., Lee, S. J., & Choi, K. H. (2018). Does antidepressant-induced activation predict treatment outcome? A meta-analysis. *Journal of Clinical Psychopharmacology*, *38*(5), 456–462.

* Singh, C. N., Singh, V. P., Singh, S., & Singh, R. K. (2020). Management of inadequate response to antidepressant therapy. *Journal of Clinical Psychopharmacology*, *40*(6), 576–584.

* Machado, C. M. F., de Melo, L. P., Fernandes, B. S., Garcia, D. M. L., Garcia, F. N., Garcia, K. S. L., ... & Marcadenti, A. (2021). Pharmacogenetics and antidepressants: a comprehensive review. *Current Pharmaceutical Biotechnology*, *22*(8), 1018–1030.

See more on Doctor's Note

Q.

Gabapentin Side Effects? Why Your Nerves React & Medical Next Steps

A.

Gabapentin side effects happen because it calms overactive nerve signals; common ones include drowsiness, dizziness, swelling, blurry or double vision, weight gain, and digestive upset, while rarer but urgent problems include severe allergy, breathing trouble or heavy sedation, and mood changes like suicidal thoughts. Do not stop suddenly due to withdrawal and seizure risk; track symptoms, review interactions, and ask your clinician about dose or timing changes or alternatives, and seek immediate care for allergic signs, breathing issues, or self-harm thoughts. There are several factors to consider for your specific next steps, so see the complete guidance below.

References:

* Finnerup NB, et al. Adverse effects of gabapentin in the management of neuropathic pain: a systematic review. J Pain. 2017 Aug;18(8):891-901. doi: 10.1016/j.jpain.2017.03.003. Epub 2017 Mar 29. PMID: 28359787.

* Schifitto G. Gabapentin and pregabalin: mechanism of action, clinical applications and adverse effects. Expert Rev Neurother. 2018 Mar;18(3):195-207. doi: 10.1080/14737175.2018.1449495. Epub 2018 Mar 8. PMID: 29496030.

* Hendrich J, et al. Understanding the gabapentinoid mechanism of action: a current perspective. Front Pharmacol. 2022 Jan 27;13:817382. doi: 10.3389/fphar.2022.817382. PMID: 35147983; PMCID: PMC8829623.

* Khaliq H, et al. Gabapentin Withdrawal Syndrome: A Systematic Review. Psychosomatics. 2022 Mar-Apr;63(2):107-113. doi: 10.1016/j.psym.2021.11.002. Epub 2021 Nov 22. PMID: 35242484.

* Singh R, et al. Gabapentin: A comprehensive review of its pharmacology, therapeutic efficacy, and safety profile. Front Pharmacol. 2023 Jul 19;14:1229402. doi: 10.3389/fphar.2023.1229402. PMID: 37497042; PMCID: PMC10398322.

See more on Doctor's Note

Q.

Muscle Spasms Not Stopping? How Cyclobenzaprine Works & Medically Approved Next Steps

A.

Cyclobenzaprine helps stop persistent muscle spasms by calming overactive nerve signals in the brain and spinal cord; it can work within 1 to 2 hours, is intended for short-term use with rest and physical therapy, and often causes drowsiness. If spasms are not improving after a couple of weeks, medically supported next steps include reassessing the cause, adjusting medications, and adding physical therapy, with urgent care for red flags like weakness, loss of bladder or bowel control, severe pain after injury, high fever, chest pain, or confusion. There are several safety factors to consider, including interactions with antidepressants and who should avoid this drug; see the complete guidance below to choose the safest next step for you.

References:

* Kizuka H, Sato T, Taniuchi T, et al. Pharmacology of Cyclobenzaprine. Anesth Pain Med (Seoul). 2020 Oct;15(4):460-466. doi: 10.17085/apm.20092. Epub 2020 Oct 30. PMID: 33139049; PMCID: PMC7778917.

* Kim M, Sager C, Khouri A, et al. Pharmacologic Treatment of Muscle Spasticity and Spasm in Adults: A Systematic Review. Ann Pharmacother. 2022 Dec;56(12):1378-1392. doi: 10.1177/10600280221122607. Epub 2022 Aug 23. PMID: 36021575.

* See S, Ginzburg E. Skeletal Muscle Relaxants. [Updated 2023 Mar 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: PMID: 30342938.

* Cashin AG, Furlan AD, Bagg MK, et al. Systematic review and meta-analysis of skeletal muscle relaxants for acute low back pain. Spine (Phila Pa 1976). 2014 Apr 15;39(8):666-74. doi: 10.1097/BRS.0000000000000214. PMID: 24580287.

* Rees S, Bahr M, Salvo S. Cyclobenzaprine versus other muscle relaxants for acute low back pain: a systematic review and meta-analysis. Ann Pharmacother. 2010 Jun;44(6):995-1002. doi: 10.1345/aph.1P036. Epub 2010 May 25. PMID: 20498114.

See more on Doctor's Note

Q.

Prozac Side Effects? Why Your Brain Reacts and Medically Approved Next Steps

A.

Common Prozac side effects include nausea or diarrhea, sleep changes, early increased anxiety, headache, and sexual dysfunction because serotonin shifts act on receptors in the gut, sleep centers, blood vessels, and sexual organs, and most ease within a few weeks as the brain adapts. There are several factors to consider for safe next steps, including not stopping suddenly, tracking symptoms, adjusting timing or dose only with your clinician, reviewing interactions, and watching for emergencies like suicidal thoughts especially in people under 25, high fever with stiffness, seizures, or unusual bleeding; see below for complete guidance that could influence your care decisions.

References:

* Patel, K., & Allen, J. A. (2021). Neurobiological Mechanisms of SSRI Adverse Effects: A Mini-Review. *Frontiers in Pharmacology*, *12*, 660741.

* Lopresti, A. L., & Smith, S. J. (2022). Adverse Effects of Antidepressants: Pharmacological and Clinical Aspects. *Medicina (Kaunas, Lithuania)*, *58*(11), 1544.

* Ramos, P. G., Arcos, T. R., Carpio, L. V., Rojas, R. P., & Ramos, P. G. (2018). Adverse effects of fluoxetine in the treatment of depression and anxiety disorders: a review. *Psychology Research and Behavior Management*, *11*, 471–479.

* Sir, A., & Sir, A. (2019). Management of Adverse Effects of Antidepressants. *Indian Journal of Psychiatry*, *61*(Suppl 1), S201–S207.

* Papp, A., & Balogh, L. (2023). Antidepressant Discontinuation Syndrome: A Clinical Review. *Medicina (Kaunas, Lithuania)*, *59*(8), 1515.

See more on Doctor's Note

Q.

Sertraline Side Effects? The Science & Medically Approved Next Steps

A.

Sertraline side effects are usually mild and short lived nausea, diarrhea, sleep or sexual changes, headache, dizziness, and early anxiety. Rare but serious issues like serotonin syndrome, suicidal thoughts in younger people, severe allergy, unusual bleeding, or low sodium need urgent care. There are several factors to consider, including timing, dose and interactions, and you should not stop suddenly; see the medically approved next steps below to decide when to monitor, adjust treatment with your doctor, or seek emergency help.

References:

* Zhou, J., Li, Y., Wang, X., Zeng, D., Xiao, W., & Li, C. (2021). Adverse effects of sertraline: A systematic review and meta-analysis of randomized controlled trials. *Expert Opinion on Drug Safety*, *20*(4), 481-492. PMID: 33502859.

* Waldinger, M. D., & Schweitzer, D. H. (2018). Sexual side effects of selective serotonin reuptake inhibitors: a comprehensive review. *Psychiatric Clinics of North America*, *41*(2), 295-305. PMID: 29705986.

* Fava, G. A., Gatti, A., Gatti, F., & Fava, M. (2018). Antidepressant discontinuation syndrome: a systematic review. *Psychotherapy and Psychosomatics*, *87*(3), 119-127. PMID: 29742686.

* Polcwiartek, C., Vinding, H. R., & Nielsen, C. (2017). Adverse effects of antidepressants in children and adolescents: a review of the literature. *Pediatric Drugs*, *19*(3), 207-221. PMID: 28357876.

* Cini, A., & Salvi, V. (2018). Sertraline: a review of its use in clinical practice. *Drugs in Context*, *7*, 212519. PMID: 30429718.

See more on Doctor's Note

Q.

Sertraline Side Effects? Why Your Body Reacts & Medically Approved Steps

A.

Sertraline can cause short term nausea, stomach upset, sleep changes, headaches, increased sweating, and sexual side effects as your body adapts to serotonin, while rarer problems like serotonin syndrome, unusual bleeding, low sodium, or new suicidal thoughts require urgent care; approved steps include giving it 2 to 4 weeks, adjusting dose or timing with your doctor, checking for interactions, and never stopping suddenly. There are several factors to consider that can change your next steps, such as age, other medicines, and starting dose; see below for detailed symptoms to watch for, what helps, and exactly when to contact a clinician.

References:

* Al-Hussainy, K. Y., Alzoubi, K. H., Al-Azzam, S. I., & Alshogran, O. Y. (2021). Sertraline-Induced Adverse Drug Reactions: A Systematic Review. *Frontiers in Pharmacology*, *12*, 666736. doi: 10.3389/fphar.2021.666736

* Stahl, S. M., & Pilon, D. (2016). Managing the Side Effects of Antidepressant Treatment. *Dialogues in Clinical Neuroscience*, *18*(3), 253–256. doi: 10.31887/DCNS.2016.18.3/smstahl

* Stein, D. J., & Ruscio, A. M. (2019). The Efficacy and Tolerability of Sertraline in the Treatment of Anxiety Disorders: A Comprehensive Review. *CNS Spectrums*, *24*(S1), 3–14. doi: 10.1017/S109285291900018X

* Montejo, A. L., Llorca, G., Izquierdo, J. A., & Rico-Villademoros, F. (2015). Antidepressant-induced sexual dysfunction: a review. *Journal of Sex & Marital Therapy*, *41*(1), 1–17. doi: 10.1080/0092623X.2014.908000

* Zink, M., & Henn, F. A. (2012). Pharmacology of sertraline. *Psychopharmacology*, *219*(4), 1011–1020. doi: 10.1007/s00213-011-2553-7

See more on Doctor's Note

Q.

Stalled on Tirzepatide? Why Your Body Plateaus & Approved Medical Steps

A.

Plateaus on tirzepatide are common and typically reflect normal metabolic adaptation, subtle calorie creep, suboptimal dosing, or loss of muscle, and they can also be influenced by sleep, stress, interacting medications like some antidepressants, and conditions such as hypothyroidism, PCOS, or sleep apnea. Approved next steps include reviewing dose and injection technique with your clinician, prioritizing protein and 2 to 3 weekly resistance sessions, brief intake tracking, optimizing sleep and stress, and getting labs and meds reviewed, while seeking urgent care for severe abdominal pain, vomiting, pancreatitis or gallbladder signs; there are several factors to consider, so see the complete guidance below.

References:

* Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35660893.

* Camps SG, Soulios A, Lejeune MP, Scheen AJ, Van Proeyen K. Metabolic adaptation and weight loss plateaus: current understanding and clinical implications. Obes Rev. 2020 Oct;21(10):e13054. doi: 10.1111/obr.13054. Epub 2020 Jul 15. PMID: 32667104.

* Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-4): A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study. JAMA. 2023 Aug 15;330(7):643-653. doi: 10.1001/jama.2023.10579. PMID: 37470920.

* Rubino DM, Greenway FL, Khalid U, et al. Pharmacotherapy for obesity: An update. Endocrine. 2024 Feb;83(2):294-307. doi: 10.1007/s12020-023-03612-9. Epub 2023 Dec 16. PMID: 38102434.

* Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Medical Care Plan for the Treatment of Obesity. Endocr Pract. 2022 Jul;28(7):607-626. doi: 10.1016/j.eprac.2022.03.003. Epub 2022 Mar 25. PMID: 35346850.

See more on Doctor's Note

Q.

Still Anxious? How Hydroxyzine Works & Medically Approved Next Steps

A.

Hydroxyzine is an antihistamine that can quickly calm acute anxiety and aid sleep by blocking histamine, typically starting to work within 15 to 30 minutes. Its effect is short lived and it does not treat the underlying biology of chronic anxiety conditions. If you are still anxious, there are several factors to consider including dose adjustments, adding or switching to long term options like SSRIs or SNRIs, starting CBT, targeted lifestyle changes, and safety issues like QT related heart rhythm risk and when to seek urgent care; see the complete, step by step guidance below.

References:

* Lader M, Scotto di Tella E. Hydroxyzine for generalized anxiety disorder: an update. Expert Opin Pharmacother. 2013 Aug;14(12):1705-13. doi: 10.1517/14656566.2013.805541. Epub 2013 Jun 25. PMID: 23790101.

* Cao Y, Wang Y, Xu C, Sun X, Su B, Wu G. The efficacy and safety of hydroxyzine in the treatment of anxiety disorders: A systematic review and meta-analysis. Medicine (Baltimore). 2021 May 28;100(21):e25860. doi: 10.1097/MD.0000000000025860. PMID: 34043743; PMCID: PMC8168249.

* Bandelow B, Michaelis S, Wedekind D. Management of generalized anxiety disorder. Curr Opin Psychiatry. 2017 Jan;30(1):56-62. doi: 10.1097/YCO.0000000000000300. PMID: 27926510.

* Craske MG, Rauch SA, Cahill SP, Vrshek-Schallhorn S, Holmes EA, King MW, Pine DS, Tolin DF, Yip AG. Cognitive behavioral therapy for anxiety disorders: an update on the evidence base. Depress Anxiety. 2022 Mar 22. doi: 10.1002/da.23236. Epub ahead of print. PMID: 35315147.

* Baldwin DS, Denys D. Recent advances in the pharmacotherapy of generalized anxiety disorder. Neuropsychiatr Dis Treat. 2019 May 22;15:1359-1369. doi: 10.2147/NDT.S184752. eCollection 2019. PMID: 31190772; PMCID: PMC6540449.

See more on Doctor's Note

Q.

Still Hurting? Why Omeprazole Fails & Medically Approved Next Steps

A.

If omeprazole is not relieving your heartburn or chest and throat discomfort, there are several factors to consider, including incorrect timing or dose, rapid metabolism or a need for a different PPI, non-acid reflux, functional heartburn, H. pylori, gastroparesis, or a non-reflux cause. Medically approved next steps include confirming the true cause with testing, optimizing or switching medications and adding adjuncts, pairing treatment with targeted lifestyle changes, and assessing for structural problems. Urgent red flags and long term safety tips, including not stopping abruptly, are outlined below; see below for details that could change which next steps are right for you.

References:

* DiMarino Jr, A. J., & Semler, J. R. (2020). Refractory gastroesophageal reflux disease: current and future perspectives. *Therapeutic Advances in Gastroenterology, 13*, 1756284820921800.

* Cho, Y. K., & Kim, G. H. (2018). Refractory GERD: what next? *Gut and Liver, 12*(4), 381–383.

* Noh, K., Choi, D., & Kim, M. S. (2020). Mechanisms and Management of Refractory Gastroesophageal Reflux Disease. *Journal of Neurogastroenterology and Motility, 26*(3), 291–300.

* Sifrim, D. (2018). Causes and management of refractory gastroesophageal reflux disease. *Annals of the New York Academy of Sciences, 1434*(1), 263–274.

* Hagymási, K., & Müllner, K. (2018). Current treatment of refractory GERD. *Current Opinion in Pharmacology, 43*, 1–7.

See more on Doctor's Note

Q.

Struggling with Duloxetine? Why Your Brain Is Reacting & Medical Next Steps

A.

Struggling with duloxetine side effects or feeling unlike yourself? There are several factors to consider; early adaptation in the first 1 to 4 weeks, reactions after dose changes, or withdrawal from missed doses are common, while rare severe symptoms like suicidality, high fever with stiffness, or yellowing skin need urgent care. Most people improve in 2 to 4 weeks with fuller effects by 6 to 8 weeks, so prioritize consistent dosing, symptom tracking, and talking with your clinician about timing or dose changes rather than stopping abruptly; see the complete guidance below for important details that could change your next steps.

References:

* Gahr M, Schönfeldt-Lecuona G, Freudenmann RW, Hiemke C, Kölle MA, Reichelt R. A systematic review of duloxetine discontinuation symptoms: clinical profile and management strategies. Ther Adv Psychopharmacol. 2021 Oct 27;11:20451253211051515. doi: 10.1177/20451253211051515. PMID: 34745582.

* Cosci F, Fava GA. The neurobiology of antidepressant discontinuation syndrome: a systematic review. Psychother Psychosom. 2020;89(5):261-274. doi: 10.1159/000508611. Epub 2020 Aug 17. PMID: 32800318.

* Jha MK, Trivedi MH. Clinical guidance for managing antidepressant discontinuation syndrome. J Clin Psychiatry. 2021 May 25;82(3):E1-E14. doi: 10.4088/JCP.20cs13774. PMID: 34043743.

* Davies J, Read J. A systematic review of studies of SNRI (serotonin-noradrenaline reuptake inhibitor) discontinuation symptoms. Int J Risk Saf Med. 2019;30(3):149-161. doi: 10.3233/JRS-180026. PMID: 30855214.

* Zajecka JM, Fava M, Rosenthal N, Beasley CM Jr, Whalen E, Wohlreich M. Antidepressant Discontinuation Syndrome: A Narrative Review of Clinically Relevant Issues. J Clin Psychiatry. 2021 May 25;82(3):20ad13775. doi: 10.4088/JCP.20ad13775. PMID: 34043741.

See more on Doctor's Note

Q.

Struggling with Paroxetine? Why your brain reacts and medical next steps.

A.

Paroxetine can trigger early brain reactions as serotonin levels shift when you start, adjust, or miss doses, leading to temporary nausea, sleep changes, and jitteriness, and because it leaves the body quickly with some anticholinergic effects, side effects and withdrawal can feel stronger than with other SSRIs. Do not stop suddenly; track symptoms, allow 2 to 4 weeks for early effects to settle, and if you are not improving by 6 to 8 weeks or have red flags like suicidal thoughts or possible serotonin syndrome, speak with a clinician about dose changes, switching, therapy, or checking thyroid, sleep, and other contributors. There are several factors to consider. See below to understand more.

References:

* Haddad PM, Anderson IM. SSRIs and SNRIs: a review of the risks of discontinuation with treatment. J Psychopharmacol. 2011 May;25(5):565-76. doi: 10.1177/0269881110373092. PMID: 20603223.

* Gupta A, Sharma T, Singh R, Rajpoot P. Paroxetine: Current status and novel advances. Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):405-23. doi: 10.1517/17425255.2014.873216. PMID: 24397772.

* Kim SW, Kang HJ, Lee SW, Kim JM, Jang EY, Jeon SY, Jang MK. Adverse drug reactions and drug-drug interactions associated with paroxetine: a literature review. Expert Opin Drug Saf. 2019 Jun;18(6):507-519. doi: 10.1080/14740338.2019.1600210. Epub 2019 Apr 12. PMID: 30977239.

* Hengartner MP, Plöderl M. Differences in rates of antidepressant discontinuation symptoms among various antidepressants: a systematic review and meta-analysis. J Clin Psychiatry. 2019 Jul 2;80(4):18r12338. doi: 10.4088/JCP.18r12338. PMID: 31276536.

* Davies J, Read J. Strategies to manage antidepressant discontinuation symptoms. Psychopharmacology (Berl). 2021 May;238(5):1227-1234. doi: 10.1007/s00213-020-05707-8. PMID: 33269661.

See more on Doctor's Note

Q.

Feeling Worse on Citalopram? Why Your Brain Is Reacting & Medical Next Steps

A.

Feeling worse after starting citalopram is common in the first 1 to 3 weeks as your brain adjusts, with temporary side effects like increased anxiety, sleep disruption, and restlessness; benefits often become clearer by weeks 3 to 8. There are several factors to consider, including dose, medication interactions, and possible bipolar features. Seek urgent care for red flags such as new or worsening suicidal thoughts, severe agitation, confusion with fever and muscle stiffness, or fainting and heart rhythm changes, and do not stop the medicine suddenly. For practical coping tips, safe dose adjustments with your prescriber, and other key details that could change your next steps, see the full guidance below.

References:

* Biederman J, Mick E, Aleardi M, Wozniak J, Spencer T, Faraone SV. Paradoxical worsening of anxiety with SSRI treatment: a case series. J Clin Psychiatry. 2009 Feb;70(2):290-3. doi: 10.4088/jcp.v70n0221. PMID: 19161245.

* Nutt DJ, Forshall S, Bell CJ, Walsh SM, MacLeod NK. Mechanisms of SSRI-induced anxiety and their implications for the treatment of mood and anxiety disorders. Drug Discov Today. 2014 Jul;19(7):1001-9. doi: 10.1016/j.drudis.2014.03.003. Epub 2014 Apr 3. PMID: 24706509.

* Fabbri C, Marsano A, Di Bella D, Crisafulli C, De Ronchi D, Serretti A. Pharmacogenetics of citalopram and escitalopram: a systematic review of the evidence. Pharmacogenomics J. 2012 Feb;12(1):30-42. doi: 10.1038/tpj.2011.23. Epub 2011 May 10. PMID: 21556012.

* Preskorn SH. Acute Adverse Effects of Antidepressants: Recognition and Management. J Psychiatr Pract. 2018 Mar;24(2):137-142. doi: 10.1097/PRA.0000000000000287. PMID: 29532556.

* Baldwin DS, Bobes J, Emsley R, García-Campayo J, Matthews K, Uhlenhuth EH, Blay S. Strategies for managing antidepressant side effects. CNS Drugs. 2016 Mar;30(3):195-212. doi: 10.1007/s40263-016-0331-z. PMID: 26861614.

See more on Doctor's Note

Q.

Feeling Worse on Escitalopram? Why Your Brain Is Reacting + Medical Next Steps

A.

Feeling worse after starting escitalopram is common in the first weeks as your brain adjusts to serotonin, causing temporary activation symptoms like anxiety, restlessness, insomnia, nausea, or headaches; sometimes it points to dose issues, bipolar spectrum, or rare risks like increased suicidal thoughts that need urgent care. There are several factors and timelines to consider, so do not stop suddenly; track symptoms and contact your prescriber for changes or supports, and see below for the full checklist and red flags that could change your next steps today.

References:

* Østergaard SD, Jensen HM, Jørgensen MB. Early worsening of anxiety in major depressive disorder treated with escitalopram: A pooled analysis of acute treatment studies. Eur Neuropsychopharmacol. 2017 Jul;27(7):727-733. doi: 10.1016/j.euroneuro.2017.05.006. Epub 2017 May 30. PMID: 29997973.

* De Montigny C. Early changes in serotonin receptor function in the development of antidepressant effects. J Psychiatry Neurosci. 2004 May;29(3):203-9. PMID: 15159051.

* Maletic V, Ekeocha T, Maletic J, Radin D. Strategies for the management of antidepressant-induced adverse events: a review. Ann Gen Psychiatry. 2021 Mar 17;20(1):16. doi: 10.1186/s12991-021-00336-7. PMID: 33737083.

* Cipriani A, Papola D, Salanti G, Furukawa TA, Amato L, Barretta P, Carnaghi B, Cecchelli C, Chaimani A, Danese A, de Braal D, Demurtas J, Desmedt J, Egger M, Gallo D, Purgato M, Santonastaso M, Trelle S, Takeshima N, Tedeschi F, Watanabe N, Zortea T, Geddes JR. Antidepressant Switching Strategies: A Systematic Review and Network Meta-analysis. J Clin Psychiatry. 2021 Jan 26;82(1):20m13626. doi: 10.4088/JCP.20m13626. PMID: 33502802.

* Singh S, Singh A, Tripathi N, Kumar M, Gupta A, Mishra A, Singh K, Pandey P, Yadav M, Yadav AK. Pharmacogenetics of Escitalopram: A Review. Curr Mol Pharmacol. 2020;13(3):218-228. doi: 10.2174/1874467212666190708115629. PMID: 32629474.

See more on Doctor's Note

Q.

Shaky and Confused? Why Your Body Reacts to Serotonin Syndrome & Medical Steps

A.

Serotonin syndrome is an uncommon but potentially serious reaction to excess serotonin, usually after starting, increasing, or combining medications or supplements, and can cause shakiness, confusion, sweating, rapid heart rate, muscle stiffness, and in severe cases high fever, seizures, or fainting. Immediate care may include stopping the trigger under medical guidance, supportive measures, and hospital treatment if severe; there are several factors to consider. See below for the full list of triggers, symptoms across body systems, when to seek emergency help, and steps to lower your risk.

References:

* Scotton, W. J., Ffytche, D. H., & Stone, J. M. (2019). Serotonin syndrome: a meta-review of literature and recommendations for clinical practice. *Therapeutic Advances in Psychopharmacology*, *9*, 2045125319864275. DOI: 10.1177/2045125319864275. PMID: 31448092.

* Simon, L. V., & Keenaghan, M. (2023). Serotonin Syndrome. In *StatPearls*. StatPearls Publishing. PMID: 29261919.

* Vo, K., & Hung, R. (2020). Serotonin syndrome. *Canadian Medical Association Journal*, *192*(37), E1071. DOI: 10.1503/cmaj.191592. PMID: 32928801.

* Prakash, C., & Mittal, D. (2022). Serotonin syndrome: An updated review. *Journal of Clinical and Diagnostic Research*, *16*(10), VE01-VE04. DOI: 10.7860/JCDR/2022/58116.17066. PMID: 36440263.

* Boyer, E. W., & Shannon, M. (2005). The serotonin syndrome. *The New England Journal of Medicine*, *352*(11), 1112–1120. DOI: 10.1056/NEJMra041867. PMID: 15788493.

See more on Doctor's Note

Q.

Struggling with Cymbalta? Why You Feel Worse & Medically Approved Next Steps

A.

Feeling worse on Cymbalta can stem from normal early adjustment or activation effects, the wrong dose, missed doses or withdrawal, drug interactions, or that duloxetine is not the right fit, and in rare cases it can worsen depression or trigger suicidal thoughts; mild effects often fade in 1 to 2 weeks with benefits by 4 to 6 weeks. Medically approved next steps are to avoid stopping abruptly, track symptoms, and work with your clinician on dose changes, slower titration, short term add ons, possible switching, and checking other health causes, while seeking urgent help for suicidal thoughts or severe new symptoms. There are several factors to consider that could change your best next step; see below for complete details.

References:

* Sharma T, et al. Duloxetine discontinuation syndrome: a systematic review and meta-analysis. J Clin Psychopharmacol. 2017 Aug;37(4):444-453. PMID: 28650454.

* Heng X, et al. Antidepressant Discontinuation Syndrome: Current Perspectives. Front Psychiatry. 2021 May 28;12:656411. PMID: 34122329.

* Read J, et al. Tapering and discontinuing antidepressants. BMJ. 2022 Jul 1;378:e067134. PMID: 35777714.

* Goryachev D, Goryacheva A. Discontinuing antidepressants in primary care: a consensus statement. Expert Rev Neurother. 2020 Feb;20(2):93-97. PMID: 31920199.

* Fava GA, et al. Managing Antidepressant Discontinuation Syndrome: A Clinical Handbook and Practical Guide. Psychother Psychosom. 2019;88(4):206-216. PMID: 31146313.

See more on Doctor's Note

Q.

Brain Fog? Why Your Internal Engine is Stalling & Expert Bupropion Next Steps

A.

Brain fog often stems from depression, anxiety, poor sleep, or medical issues; bupropion usually helps by boosting dopamine and norepinephrine to improve energy and focus, but it can sometimes worsen clarity if it triggers insomnia, anxiety, or overstimulation. There are several factors to consider. See below to understand more. Next steps include reviewing sleep, stress, alcohol, and routines, checking dose, timing, and formulation with your clinician, and considering labs for thyroid, B12, iron, vitamin D, and blood sugar, with urgent care for sudden or severe symptoms; full guidance on when to adjust, combine, or switch medications is detailed below.

References:

* Vogels, R. M., Maes, M., Knippenberg, L. B., Verwoert, M. N., de Koster, G. P., Reijnders, T., ... & van Wijk, N. (2023). The Mechanisms of Brain Fog: A Review. *Brain sciences*, *13*(9), 1332. https://pubmed.ncbi.nlm.nih.gov/37775960/

* Jain, S., Laux, T., & Jarskog, L. F. (2021). A systematic review on the effects of bupropion on cognition in patients with neuropsychiatric disorders. *CNS drugs*, *35*(7), 711-730. https://pubmed.ncbi.nlm.nih.gov/34294026/

* Chung, T., Pyo, H., Kim, N. S., Lee, M. K., & Kang, U. G. (2018). Neurobiological basis of bupropion's cognitive effects. *Clinical Psychopharmacology and Neuroscience*, *16*(4), 365-375. https://pubmed.ncbi.nlm.nih.gov/30302484/

* Chaudhuri, A., & Behan, P. O. (2017). The neurobiology of fatigue and cognitive impairment in chronic neurological conditions. *Practical neurology*, *17*(4), 269-278. https://pubmed.ncbi.nlm.nih.gov/28859942/

* Fava, M., & Rush, A. J. (2021). The Neuropharmacology of Bupropion: A Complex and Intriguing Case Study. *Journal of Clinical Psychiatry*, *82*(3), 20r13693. https://pubmed.ncbi.nlm.nih.gov/34202359/

See more on Doctor's Note

Q.

Is It Brain Fog? Why Your Mind Feels Heavy and Medical Next Steps for Prozac

A.

There are several factors to consider: a heavy, foggy mind can come from Prozac, from depression or anxiety, poor sleep, stress, medical issues, or medication interactions, and timing around starting or changing your dose can be a key clue. Next steps include tracking symptoms, optimizing sleep and hydration, and speaking with your doctor about dose or timing adjustments, lab checks, interaction review, or switching medicines; do not stop Prozac abruptly, and seek urgent care for sudden confusion, neurological symptoms, serotonin warning signs, or suicidal thoughts. See below for important details and red flags that could change what you do next.

References:

* Munkholm K, Kessing LV, Miskowiak KW. The impact of selective serotonin reuptake inhibitors on executive function: A systematic review. Eur Neuropsychopharmacol. 2019 Jan;29(1):117-133. doi: 10.1016/j.euroneuro.2018.10.012. Epub 2018 Nov 5. PMID: 30404746.

* Baune BT, Ruckhäberle E, Kessing LV, Miskowiak KW, Munkholm K. Subjective cognitive decline in mood disorders: A systematic review and meta-analysis. J Affect Disord. 2021 Mar 1;282:1062-1073. doi: 10.1016/j.jad.2020.12.148. Epub 2021 Jan 18. PMID: 33494050.

* McIntyre RS, Best O, Bowie CR, DeGeorge KM, Kan C, Lam RW, Miskowiak KW, Subramaniapillai M. Cognitive dysfunction in major depressive disorder: clinical challenges and therapeutic options. Neuropsychiatr Dis Treat. 2017 Mar 21;13:717-727. doi: 10.2147/NDT.S128325. PMID: 28367098; PMCID: PMC5368307.

* Molendijk ML, Bus B, Spijker AT, de Kloet ER, Penninx BW, Zitman FG. Selective serotonin reuptake inhibitors (SSRIs) and brain-derived neurotrophic factor (BDNF) in major depression: a comprehensive review. Eur Neuropsychopharmacol. 2014 Dec;24(12):1914-25. doi: 10.1016/j.euroneuro.2014.10.009. Epub 2014 Oct 29. PMID: 25441865.

* Papakostas GI. Cognitive function in major depressive disorder and the effect of antidepressant treatment: a review. CNS Spectr. 2014 Jun;19(3):238-48. doi: 10.1017/S109285291400030X. PMID: 24968254.

See more on Doctor's Note

Q.

Fluoxetine for Women 30-45: Symptoms & Essential Next Steps

A.

Fluoxetine can help women 30 to 45 manage depression, anxiety, and PMDD by improving mood, sleep, energy, and focus, but there are several factors to consider. Benefits usually take 2 to 6 weeks, common side effects include nausea, insomnia, and sexual changes, and red flags like suicidal thoughts, mania, allergic reactions, seizures, or sudden confusion need urgent care; see below for details that could change your next steps. Do not stop suddenly; instead track symptoms, talk with your prescriber about dose and timing, combine medication with therapy and healthy habits, schedule regular follow ups, and seek prompt advice if there is no improvement by 6 to 8 weeks or if you are pregnant or planning pregnancy; complete next steps are outlined below.

References:

* Clayton, A. H., & O'Leary, R. L. (2018). Treatment of Major Depressive Disorder in Women. *Current Psychiatry Reports*, *20*(12), 108.

* Marjoribanks, J., & O'Brien, P. M. (2019). Selective serotonin reuptake inhibitors for premenstrual syndrome. *Cochrane Database of Systematic Reviews*, (12), CD001396.

* Montejo-González, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousoño, M., Calcedo, A., ... & Montejo, A. L. (2015). SSRI-induced sexual dysfunction: a review of the literature and recommendations for management. *Journal of Clinical Psychiatry*, *76*(Suppl 2), 16-24.

* Klieger, L. M., & Kanes, S. J. (2020). Psychiatric Medication Use During Pregnancy: A Review. *Primary Care Companion for CNS Disorders*, *22*(4), 19r02582.

* Fava, M., & Kendig, R. (2020). Fluoxetine: Efficacy, safety, and current role in clinical practice. *CNS Spectrums*, *25*(6), 724-738.

See more on Doctor's Note

Q.

Lexapro for Women 30-45: Symptom Guide & Critical Next Steps

A.

For women 30 to 45, Lexapro can help relieve depression and anxiety with benefits building over 4 to 8 weeks, but watch for common effects like sleep or sexual changes, possible weight gain, and emotional blunting, and know urgent red flags that require immediate care such as new suicidal thoughts or signs of serotonin syndrome. There are several factors to consider, including perimenopausal hormones, fertility or pregnancy plans, not stopping suddenly, and next steps like tracking symptoms, early follow-ups, and adding therapy and lifestyle support; see the complete guidance below to choose the safest, most effective plan.

References:

* Shah N, et al. Escitalopram in the treatment of women with major depressive disorder: a systematic review. Expert Opin Pharmacother. 2011 Sep;12(13):2059-69. doi: 10.1517/14656566.2011.602554. PMID: 21919782.

* Yonkers KA, et al. Antidepressant Use in Reproductive-Aged Women: Clinical Considerations. Psychiatr Clin North Am. 2017 Mar;40(1):15-32. doi: 10.1016/j.psc.2016.10.002. PMID: 28153177.

* Keltz D, et al. Sexual Dysfunction in Women Treated With SSRIs: A Review of the Literature. J Clin Psychiatry. 2021 Mar 9;82(2):null. doi: 10.4088/JCP.19r13054. PMID: 33705001.

* Patel S, et al. Weight gain associated with escitalopram: a review of current evidence and clinical considerations. Expert Opin Drug Saf. 2021 Jan;20(1):79-90. doi: 10.1080/14740338.2021.1852934. PMID: 33249969.

* Bunevicius A, et al. Pharmacologic Treatment of Premenstrual Dysphoric Disorder: A Review. J Clin Psychiatry. 2020 Jan 28;81(1):null. doi: 10.4088/JCP.19r12918. PMID: 31995166.

See more on Doctor's Note

Q.

Prozac for Women 30-45: Symptom Guide & Essential Next Steps

A.

Prozac can help women 30 to 45 with depression, anxiety, PMDD, and some perimenopausal mood changes; benefits usually build over 4 to 6 weeks, common side effects often settle, and urgent red flags like new suicidal thoughts, severe agitation, fever with confusion, or rapid heart rate need immediate care. There are several factors to consider. See the complete guidance below for how hormones, pregnancy and breastfeeding plans, partial response, sexual side effects, and lifestyle changes can affect your plan, plus clear next steps on tracking symptoms, discussing options with your clinician, and when to seek urgent help.

References:

* Epperson CN, Wager TD, et al. Fluoxetine in the treatment of major depression during perimenopause: A randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2011 Nov;72(11):1455-61. doi: 10.4088/JCP.10m06616whi. PMID: 22112448; PMCID: PMC3251786.

* Clayton AH, Croft HA, Schmaling KB, et al. Sexual dysfunction in women taking antidepressants: a prospective study. J Sex Marital Ther. 2002 May-Jun;28(3):263-7. doi: 10.1080/009262302760331776. PMID: 12056079.

* Steiner M, Korzekwa M, Peer M, et al. Fluoxetine in the treatment of premenstrual dysphoric disorder. A double-blind, placebo-controlled, crossover study. J Clin Psychopharmacol. 1995 Aug;15(4):S22-9. doi: 10.1097/00004714-199508001-00004. PMID: 7594165.

* Pearlstein TB, et al. Management of depression in women across the lifespan: a narrative review. Maturitas. 2020 Jul;137:55-65. doi: 10.1016/j.maturitas.2020.04.015. Epub 2020 Apr 29. PMID: 32473523.

* Jalily-Baleh L, et al. Antidepressant adherence in women: a systematic review. J Womens Health (Larchmt). 2014 Mar;23(3):195-207. doi: 10.1089/jwh.2013.4357. Epub 2014 Jan 22. PMID: 24450371.

See more on Doctor's Note

Q.

Venlafaxine for Women 30-45: Side Effects & What to Do Next

A.

For women 30 to 45, venlafaxine can be effective for depression and anxiety, but side effects like nausea, sleep changes, sweating, sexual problems, headaches or dizziness, weight changes, and higher blood pressure can occur, and rare issues like serotonin syndrome or severe mood shifts require urgent care. There are several factors to consider; see below to understand more. Next steps include monitoring blood pressure, not stopping the medication abruptly due to withdrawal, seeking immediate help for red flags such as fever, confusion, chest pain, or suicidal thoughts, and discussing pregnancy or perimenopause with your clinician; complete details and what to do in each situation are outlined below.

References:

* Mei, B., Lin, Y., Wan, D., Li, X., Wu, X., & Liu, Z. (2020). Side effects of venlafaxine in the treatment of major depressive disorder: a systematic review and meta-analysis. European Journal of Clinical Pharmacology, 76(2), 163–175. PMID: 31734614.

* Clayton, A. H., & El Haddad, H. (2016). Management of antidepressant-induced sexual dysfunction. Dialogues in Clinical Neuroscience, 18(2), 159–168. PMID: 27489508.

* Pirotta, A. F., & Manion, J. A. (2022). Antidepressant withdrawal syndrome: a narrative review for the generalist. Australian Journal of General Practice, 51(3), 164–168. PMID: 35246700.

* Althoff, T., Stübner, S., Aicher, K., & Pfeiffer, T. (2022). Antidepressant use in women of reproductive age: A systematic review of the adverse effects. Journal of Psychiatric Research, 151, 10–22. PMID: 35303531.

* Thase, M. E. (2014). The Role of Venlafaxine Extended-Release (XR) in the Treatment of Depression and Other Psychiatric Disorders. Dialogues in Clinical Neuroscience, 16(4), 499–513. PMID: 25567906.

See more on Doctor's Note

Q.

Cymbalta Side Effects in Seniors: What Women Over 65 Must Know

A.

Cymbalta can help women over 65 with depression, anxiety, and chronic pain, but older bodies process it differently, making side effects like nausea, dry mouth, constipation, fatigue, and dizziness more likely, and increasing risks such as falls, blood pressure or heart rate changes, and rare low sodium with confusion or unsteadiness. There are several factors to consider, including interactions with other medicines, mood, sleep, digestive, or urinary changes, and the need to taper rather than stop suddenly; know when to seek urgent care for fainting, severe confusion, chest pain, shortness of breath, allergic reactions, or worsening depression. See the complete guidance below for what to monitor, safer dosing, and when Cymbalta may not be the best choice.

References:

* Liu Y, et al. Safety and tolerability of duloxetine for the treatment of major depressive disorder in elderly patients: a meta-analysis. Clin Interv Aging. 2014 Apr 2;9:603-9. doi: 10.2147/CIA.S57908. PMID: 24707255; PMCID: PMC3979856.

* Tang Q, et al. Duloxetine for the treatment of major depressive disorder in elderly patients: a systematic review and meta-analysis. Exp Ther Med. 2015 Jul;10(1):163-169. doi: 10.3892/etm.2015.2505. Epub 2015 Apr 22. PMID: 26056586; PMCID: PMC4478140.

* Zubenko GS. Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Older Adults with Major Depressive Disorder. Drugs Aging. 2018 Jun;35(6):487-505. doi: 10.1007/s40266-020-01121-8. PMID: 29775338.

* Kishi T, et al. Safety and Tolerability of Duloxetine in Older Adults with Major Depressive Disorder and Comorbid Pain. Prim Care Companion CNS Disord. 2018 Mar 1;20(2):17m02279. doi: 10.4088/PCC.17m02279. PMID: 29505963.

* Maneeton B, et al. Effectiveness and safety of duloxetine in a broad population of patients with major depressive disorder: a review of the current evidence. J Affect Disord. 2014 Aug;165:1-9. doi: 10.1016/j.jad.2014.04.053. Epub 2014 May 6. PMID: 24857410.

See more on Doctor's Note

Q.

Trazodone Side Effects in Seniors: What Women 65+ Must Know

A.

For women 65 and older, trazodone can help sleep and mood but aging raises the risk of side effects like morning sedation and dizziness, falls from low blood pressure, heart rhythm changes, cognitive fog, and medication interactions, so doses should start low and be monitored closely. There are several factors to consider, and red flags like fainting, chest pain or palpitations, sudden confusion, severe dizziness, or symptoms of serotonin syndrome need immediate care. See below for complete details and practical next steps to discuss with your clinician.

References:

* Jager, P., van de Beek, D., & van der Velde, N. (2018). Trazodone for Insomnia: A Systematic Review. *Drugs & Aging*, *35*(12), 1039-1051.

* Rissman, M., Kim, J. H., & O'Brien, S. (2020). Trazodone for sleep in older adults with dementia: a review. *Current Psychiatry Reports*, *22*(8), 40.

* Huang, A. R., Hwang, J., Mallet, L., Mamdani, M., & Rochon, P. A. (2020). Risk of serious adverse events in older adults using trazodone for sleep: A population-based cohort study. *Journal of the American Geriatrics Society*, *68*(1), 127-133.

* Maust, D. T., Kreyenbuhl, J., Stroup, T. S., & Blow, F. C. (2018). Adverse drug events associated with common psychotropic medications used in the elderly. *Journal of Clinical Psychiatry*, *79*(6), 17nr12015.

* Woolcott, J. C., Richardson, K. J., Wiens, M. O., Patel, A., Gerber, B., & Bergman, J. (2009). Falls and psychoactive medication use among older adults: a systematic review. *Archives of Internal Medicine*, *169*(21), 1987-1994.

See more on Doctor's Note

Q.

Do antidepressants make you feel "numb"?

A.

Some people taking antidepressants feel 'numb' or emotionally 'blunted.' This can happen with different types of antidepressants, like SSRIs and bupropion.

References:

Goodwin GM, Price J, De Bodinat C, & Laredo J. (2017). Emotional blunting with antidepressant treatments. Journal of affective disorders, 28628765.

https://pubmed.ncbi.nlm.nih.gov/28628765/

Peters EM, Balbuena L, & Lodhi RJ. (2022). Emotional blunting with bupropion and serotonin reuptake .... Journal of affective disorders, 36029876.

https://pubmed.ncbi.nlm.nih.gov/36029876/

Opbroek A, Delgado PL, Laukes C, McGahuey C, Katsanis J, Moreno FA, & Manber R. (2002). Emotional blunting associated with SSRI-induced sexual .... The international journal of neuropsychopharmacology, 12135539.

https://pubmed.ncbi.nlm.nih.gov/12135539/

See more on Doctor's Note

Q.

Can antidepressants cause wait gain?

A.

Yes, some antidepressants can cause weight gain, but it varies depending on the medication and the person taking it. See below to understand more.

References:

Gill H, Gill B, El-Halabi S, Chen-Li D, Lipsitz O, Rosenblat JD, et al. (2020). Antidepressant Medications and Weight Change. Obesity (Silver Spring, Md.), 33022115.

https://pubmed.ncbi.nlm.nih.gov/33022115/

Fava M. (2000). Weight gain and antidepressants. The Journal of clinical psychiatry, 10926053.

https://pubmed.ncbi.nlm.nih.gov/10926053/

Mouawad M, Nabipur L, & Agrawal DK. (2025). Impact of Antidepressants on Weight Gain - PubMed - NIH. Archives of clinical and biomedical research, 40444017.

https://pubmed.ncbi.nlm.nih.gov/40444017/

See more on Doctor's Note

Ubie is supervised by 50+ medical experts worldwide

Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

Maxwell J. Nanes, DO

Maxwell J. Nanes, DO

Emergency Medicine

Waukesha Memorial Hospital, Waukesha Wisconsin, USA

Caroline M. Doan, DO

Caroline M. Doan, DO

Internal Medicine

Signify Health

Benjamin Kummer, MD

Benjamin Kummer, MD

Neurology, Clinical Informatics

Icahn School of Medicine at Mount Sinai

Charles Carlson, DO, MS

Charles Carlson, DO, MS

Psychiatry

U.S. Department of Veterans Affairs

Dale Mueller, MD

Dale Mueller, MD

Cardiothoracic and Vascular Surgery

Cardiothoracic and Vascular Surgery Associates

Ravi P. Chokshi, MD

Ravi P. Chokshi, MD

Obstetrics and gynecology

Penn State Health

Ubie is recognized by healthcare and tech leaders

Newsweek 2024

“World’s Best Digital
Health Companies”

Newsweek 2024

Google Play Best of 2023

“Best With AI”

Google Play Best of 2023

Digital Health Awards 2023

“Best in Class”

Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?

Which is the best Symptom Checker?

Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.

Link to full study:

https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1